NITRIC-OXIDE PRODUCTION FROM MACROPHAGES IS REGULATED BY ARACHIDONIC-ACID METABOLITES

被引:46
作者
IMAI, Y [1 ]
KOLB, H [1 ]
BURKART, V [1 ]
机构
[1] UNIV DUSSELDORF,DIABET RES INST,HENNEKAMP 65,D-40225 DUSSELDORF,GERMANY
关键词
D O I
10.1006/bbrc.1993.2447
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In activated macrophages the inducible form of the enzyme nitric oxide (NO) synthase generates high amounts of the toxic mediator NO. After 20 h of treatment with LPS rat peritoneal macrophages release 12-16 nmol NO2-/105 cells which is detectable in the culture supernatant by the Griess reaction as a measure of NO formation. The addition of aminoguanidine (1 mM), a preferential inhibitor of the inducible NO-synthase, completely abolished NO2- accumulation. Incubation with indomethacin or acetyl-salicylic acid, preferential inhibitors of the cyclooxygenase pathway of the arachidonic acid metabolism, did not influence NO2- levels. Nordihydro-guaiaretic acid (50 μM), a preferential inhibitor of the lipoxygenase pathway, caused strong reduction of NO2- accumulation to 1.9 ± 0.3 nmol/200 μl. Simultaneous inhibition of cyclo- and lipoxygenase by BW755c resulted in an intermediate effect (7.3 ± 1.1 nmol/200 μl NO2-). These results show that the induction of NO production in activated macrophages is regulated by products of the lipoxygenase-pathway of the arachidonic acid metabolism. © 1993 Academic Press, Inc.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 20 条
  • [1] BURKART V, 1993, CLIN EXP IMMUNOL, V93, P273
  • [2] DIHYDROLIPOIC ACID PROTECTS PANCREATIC-ISLET CELLS FROM INFLAMMATORY ATTACK
    BURKART, V
    KOIKE, T
    BRENNER, HH
    IMAI, Y
    KOLB, H
    [J]. AGENTS AND ACTIONS, 1993, 38 (1-2): : 60 - 65
  • [3] AMINOGUANIDINE, A NOVEL INHIBITOR OF NITRIC-OXIDE FORMATION, PREVENTS DIABETIC VASCULAR DYSFUNCTION
    CORBETT, JA
    TILTON, RG
    CHANG, K
    HASAN, KS
    IDO, Y
    WANG, JL
    SWEETLAND, MA
    LANCASTER, JR
    WILLIAMSON, JR
    MCDANIEL, ML
    [J]. DIABETES, 1992, 41 (04) : 552 - 556
  • [4] REGULATION OF NITRIC-OXIDE PRODUCTION BY STIMULATED RAT KUPFFER CELLS
    GAILLARD, T
    MULSCH, A
    BUSSE, R
    KLEIN, H
    DECKER, K
    [J]. PATHOBIOLOGY, 1991, 59 (04) : 280 - 283
  • [5] INVITRO EFFECT OF N-METHOXY-3-(3,5-DITERT-BUTYL-4-HYDROXY-BENZYLIDENE)-2-PYRROLIDONE (E-5110), A NOVEL NONSTEROIDAL ANTIINFLAMMATORY AGENT, ON GENERATION OF SOME INFLAMMATORY MEDIATORS
    KATAYAMA, K
    SHIROTA, H
    KOBAYASHI, S
    TERATO, K
    IKUTA, H
    YAMATSU, I
    [J]. AGENTS AND ACTIONS, 1987, 21 (3-4): : 269 - 271
  • [6] NITRIC-OXIDE - A PATHOGENETIC FACTOR IN AUTOIMMUNITY
    KOLB, H
    KOLBBACHOFEN, V
    [J]. IMMUNOLOGY TODAY, 1992, 13 (05): : 157 - 159
  • [7] ACTIVATED MACROPHAGES KILL PANCREATIC SYNGENEIC ISLET CELLS VIA ARGININE-DEPENDENT NITRIC-OXIDE GENERATION
    KRONCKE, KD
    KOLBBACHOFEN, V
    BERSCHICK, B
    BURKART, V
    KOLB, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) : 752 - 758
  • [8] ROLE OF LIPOXYGENASE PRODUCTS IN MURINE PULMONARY GRANULOMA-FORMATION
    KUNKEL, SL
    CHENSUE, SW
    MOUTON, C
    HIGASHI, GI
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (02) : 514 - 524
  • [9] MODULATION OF THE INDUCTION OF NITRIC-OXIDE SYNTHASE BY EICOSANOIDS IN THE MURINE MACROPHAGE CELL-LINE J774
    MAROTTA, P
    SAUTEBIN, L
    DIROSA, M
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 640 - 641
  • [10] MONCADA S, 1991, PHARMACOL REV, V43, P109